M
688062
vs
U
USBC
M
688062
U
USBC
Over the past 12 months, Mabwell Shanghai Bioscience Co Ltd has underperformed USBC, delivering a return of +70% compared to the USBC's +429 900% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
688062
USBC
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
Mabwell Shanghai Bioscience Co Ltd Intrinsic Value
HIDDEN
USBC Intrinsic Value
HIDDEN
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
M
|
Mabwell Shanghai Bioscience Co Ltd
SSE:688062
|
35.23
CNY
|
|||||
|
U
|
US BioTec Inc
OTC:USBC
|
0.43
USD
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
688062, USBC
688062, USBC
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
M
|
Mabwell Shanghai Bioscience Co Ltd
Revenue
|
|||||||||||
|
U
|
US BioTec Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
688062, USBC
688062, USBC
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
M
|
Mabwell Shanghai Bioscience Co Ltd
SSE:688062
|
|||||||||
|
U
|
US BioTec Inc
OTC:USBC
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
Mabwell Shanghai Bioscience Co Ltd
88.7%
USBC
0%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
M
|
Mabwell Shanghai Bioscience Co Ltd | ||||
|
U
|
US BioTec Inc | ||||
Operating Margin
Mabwell Shanghai Bioscience Co Ltd
-137%
USBC
0%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
M
|
Mabwell Shanghai Bioscience Co Ltd | ||||
|
U
|
US BioTec Inc | ||||
Net Margin
Mabwell Shanghai Bioscience Co Ltd
-151.7%
USBC
0%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
M
|
Mabwell Shanghai Bioscience Co Ltd | ||||
|
U
|
US BioTec Inc | ||||
FCF Margin
Mabwell Shanghai Bioscience Co Ltd
-100.3%
USBC
0%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
M
|
Mabwell Shanghai Bioscience Co Ltd | ||||
|
U
|
US BioTec Inc | ||||
ROE
Mabwell Shanghai Bioscience Co Ltd
-70.8%
USBC
-51.3%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
M
|
Mabwell Shanghai Bioscience Co Ltd | ||||
|
U
|
US BioTec Inc | ||||
ROA
Mabwell Shanghai Bioscience Co Ltd
-21%
USBC
-37.8%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
M
|
Mabwell Shanghai Bioscience Co Ltd | ||||
|
U
|
US BioTec Inc | ||||
ROIC
Mabwell Shanghai Bioscience Co Ltd
-24.1%
USBC
-31.3%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
M
|
Mabwell Shanghai Bioscience Co Ltd | ||||
|
U
|
US BioTec Inc | ||||
ROCE
Mabwell Shanghai Bioscience Co Ltd
-31.5%
USBC
-30.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
M
|
Mabwell Shanghai Bioscience Co Ltd | ||||
|
U
|
US BioTec Inc | ||||
Solvency Comparison
M
Mabwell Shanghai Bioscience Co L...
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
688062, USBC
688062, USBC
Performance Gap
688062, USBC
688062, USBC
Performance Gap Between 688062 and USBC
HIDDEN
Performance By Year
688062, USBC
688062, USBC
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 688062 to other stocks
PNEXF
Pharnext SCA
ABBV
Abbvie Inc
ATXS
Astria Therapeutics Inc
AMGN
Amgen Inc
Custom
Choose any stock
Select Stock to Compare
| FR |
|
Pharnext SCA
OTC:PNEXF
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
|
| US |
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
